The 2017 European Lung Cancer Conference (ELCC) will take place on 5–7 May 2017 at the Palaexpo Exhibition Centre, Geneva, Switzerland.
Boehringer Ingelheim will host a satellite symposium entitled ‘Sharing our knowledge in NSCLC: case interchange of real-world experience’, which will be held on Sunday 7 May 2017, 13:00–14:00 in Room C. The event will be chaired by Prof. Rolf Stahel, and will include presentations from Dr Noemí Reguart, Prof. David Gandara and Dr Maximilian Hochmair.
In addition to the symposium, there will be an oral presentation on a potential new treatment option for patients with EGFRm+ NSCLC and acquired resistance to other therapies or with pretreated advanced squamous NSCLC. There will also be four posters and two poster discussion sessions, please see below for further details.
The full ELCC 2017 programme can be found here.
Sharing our knowledge in NSCLC: case interchange of real-world experience
Sunday 7 May 2017, 13:00–14:00
Room C, Palexpo Exhibition Centre
13:00 – 13:05
Welcome and general introduction
13:05 – 13:25
Making the first decision: EGFR mutation-positive NSCLC in the advanced setting
13:25 – 13:40
Understanding choice in the treatment of squamous NSCLC: when should TKIs be considered?
13:40 – 13:55
Antiangiogenic agents beyond first-line: matching patients with treatments
13:55 - 14:00
Click here to view the invitation